170 related articles for article (PubMed ID: 20308310)
21. Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors.
Yi JM; Tsai HC; Glöckner SC; Lin S; Ohm JE; Easwaran H; James CD; Costello JF; Riggins G; Eberhart CG; Laterra J; Vescovi AL; Ahuja N; Herman JG; Schuebel KE; Baylin SB
Cancer Res; 2008 Oct; 68(19):8094-103. PubMed ID: 18829568
[TBL] [Abstract][Full Text] [Related]
22. Glioblastoma cells negative for the anti-CD133 antibody AC133 express a truncated variant of the CD133 protein.
Osmond TL; Broadley KW; McConnell MJ
Int J Mol Med; 2010 Jun; 25(6):883-8. PubMed ID: 20428792
[TBL] [Abstract][Full Text] [Related]
23. CD133/CD15 defines distinct cell subpopulations with differential in vitro clonogenic activity and stem cell-related gene expression profile in in vitro propagated glioblastoma multiforme-derived cell line with a PNET-like component.
Kahlert UD; Bender NO; Maciaczyk D; Bogiel T; Bar EE; Eberhart CG; Nikkhah G; Maciaczyk J
Folia Neuropathol; 2012; 50(4):357-68. PubMed ID: 23319191
[TBL] [Abstract][Full Text] [Related]
24. Expression profiling of GIST: CD133 is associated with KIT exon 11 mutations, gastric location and poor prognosis.
Arne G; Kristiansson E; Nerman O; Kindblom LG; Ahlman H; Nilsson B; Nilsson O
Int J Cancer; 2011 Sep; 129(5):1149-61. PubMed ID: 21064103
[TBL] [Abstract][Full Text] [Related]
25. In vitro expansion of human glioblastoma cells at non-physiological oxygen tension irreversibly alters subsequent in vivo aggressiveness and AC133 expression.
Bourseau-Guilmain E; Lemaire L; Griveau A; Hervouet E; Vallette F; Berger F; Menei P; Benoit JP; Wion D; Garcion E
Int J Oncol; 2012 Apr; 40(4):1220-9. PubMed ID: 22134773
[TBL] [Abstract][Full Text] [Related]
26. CD133 is essential for glioblastoma stem cell maintenance.
Brescia P; Ortensi B; Fornasari L; Levi D; Broggi G; Pelicci G
Stem Cells; 2013 May; 31(5):857-69. PubMed ID: 23307586
[TBL] [Abstract][Full Text] [Related]
27. Isolation and partial characterization of a new human glioblastoma cell line.
Brehar FM; Bleotu C; Stefan LM; Buzgariu W; Chivu M; Utoiu E; Matei L; Ciurea AV; Tascu A
Chirurgia (Bucur); 2009; 104(4):453-61. PubMed ID: 19886054
[TBL] [Abstract][Full Text] [Related]
28. Transcriptome analysis of CD133-positive stem cells and prognostic value of survivin in colorectal cancer.
Kim ST; Sohn I; DO IG; Jang J; Kim SH; Jung IH; Park JO; Park YS; Talasaz A; Lee J; Kim HC
Cancer Genomics Proteomics; 2014; 11(5):259-66. PubMed ID: 25331798
[TBL] [Abstract][Full Text] [Related]
29. Comparative gene-expression profiling of CD133(+) and CD133(-) D10 melanoma cells.
Roudi R; Ebrahimi M; Sabet MN; Najafi A; Nourani MR; Fomeshi MR; Samadikuchaksaraei A; Shariftabrizi A; Madjd Z
Future Oncol; 2015; 11(17):2383-93. PubMed ID: 26285774
[TBL] [Abstract][Full Text] [Related]
30. Expression of glioma stem cell marker CD133 and O6-methylguanine-DNA methyltransferase is associated with resistance to radiotherapy in gliomas.
He J; Shan Z; Li L; Liu F; Liu Z; Song M; Zhu H
Oncol Rep; 2011 Nov; 26(5):1305-13. PubMed ID: 21769436
[TBL] [Abstract][Full Text] [Related]
31. Analysis of dysregulated long non-coding RNA expressions in glioblastoma cells.
Balci T; Yilmaz Susluer S; Kayabasi C; Ozmen Yelken B; Biray Avci C; Gunduz C
Gene; 2016 Sep; 590(1):120-2. PubMed ID: 27306825
[TBL] [Abstract][Full Text] [Related]
32. Heterogeneous phenotype of human glioblastoma: in vitro study.
Denysenko T; Gennero L; Juenemann C; Morra I; Masperi P; Ceroni V; Pragliola A; Ponzetto A; Melcarne A
Cell Biochem Funct; 2014 Mar; 32(2):164-76. PubMed ID: 23836332
[TBL] [Abstract][Full Text] [Related]
33. High levels of PROM1 (CD133) transcript are a potential predictor of poor prognosis in medulloblastoma.
Raso A; Mascelli S; Biassoni R; Nozza P; Kool M; Pistorio A; Ugolotti E; Milanaccio C; Pignatelli S; Ferraro M; Pavanello M; Ravegnani M; Cama A; Garrè ML; Capra V
Neuro Oncol; 2011 May; 13(5):500-8. PubMed ID: 21486962
[TBL] [Abstract][Full Text] [Related]
34. miR-125b regulates the proliferation of glioblastoma stem cells by targeting E2F2.
Wu N; Xiao L; Zhao X; Zhao J; Wang J; Wang F; Cao S; Lin X
FEBS Lett; 2012 Nov; 586(21):3831-9. PubMed ID: 22999819
[TBL] [Abstract][Full Text] [Related]
35. Elevating SOX2 levels deleteriously affects the growth of medulloblastoma and glioblastoma cells.
Cox JL; Wilder PJ; Desler M; Rizzino A
PLoS One; 2012; 7(8):e44087. PubMed ID: 22937156
[TBL] [Abstract][Full Text] [Related]
36. Members of the low-density lipoprotein receptor-related proteins provide a differential molecular signature between parental and CD133+ DAOY medulloblastoma cells.
Annabi B; Doumit J; Plouffe K; Laflamme C; Lord-Dufour S; Béliveau R
Mol Carcinog; 2010 Jul; 49(7):710-7. PubMed ID: 20564348
[TBL] [Abstract][Full Text] [Related]
37. An innovative three-dimensional gelatin foam culture system for improved study of glioblastoma stem cell behavior.
Yang MY; Chiao MT; Lee HT; Chen CM; Yang YC; Shen CC; Ma HI
J Biomed Mater Res B Appl Biomater; 2015 Apr; 103(3):618-28. PubMed ID: 24966152
[TBL] [Abstract][Full Text] [Related]
38. High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals.
Cortes-Dericks L; Galetta D; Spaggiari L; Schmid RA; Karoubi G
Eur J Cardiothorac Surg; 2012 Jun; 41(6):e173-81. PubMed ID: 22529186
[TBL] [Abstract][Full Text] [Related]
39. [Application of genome-wide genechip for screening and identifying genes related to CD133(+)CD200(+) colorectal cancer stem cells].
Zhang S; Li L; Huang Z; Xin X; Xiao B
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Dec; 33(12):1787-91. PubMed ID: 24369246
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of Prominin 1/CD133 expression in colorectal cancer by NSAIDs following short-term preoperative treatment.
Lönnroth C; Andersson M; Nordgren S; Lundholm K
Int J Oncol; 2012 Jul; 41(1):15-23. PubMed ID: 22552364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
